Dr M.P. Ram Prabu

Department: Cancer care

Designation: Senior Consultant (Medical Oncology)

Qualification: M.B.B.S, M.D, D.M

Book an appointment

Dr Ram Prabu has an overall experience of 17 years and is currently working as a Senior Consultant Medical Oncologist at Gleneagles Global Hospitals. He has participated in various conferences like International Allergy & Asthma update 2005, JIPMER, Pondicherry, International symposium on Recent Advances in Paediatric Oncology Oct 2007, AIIMs, National Hematology Update – VI, March 2007, AIIMS. He is an esteemed member of Indian Medical Association.


17 Years of Experience


  • Feb 2017 to Present

Senior Consultant Medical Oncologist, Gleneagles Global Hospitals

  • July 2011 to Feb 2017

Consultant Medical Oncologist, Miot Hospitals

  • July 2008 to July 2011

Senior Residency (DM Medical Oncology)

  • Feb 2007 to June 2008

Senior Residency (Non-DM in Medical Oncology)

  • Apr 2006 to Oct 2006

Senior Residency (General Medicine), JIPMER

  • Apr 2003 to Apr 2006

Junior Residency (General Medicine), JIPMER


  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Breast, Colorectal, Head & Neck, Ovarian Cancers


  • Lymphocytosis and chronic leukaemia. Prabu R, Kumar L. Natl Med J India. 2009 Mar-Apr;22(2):75-6.
  • Systemic reaction to leucovorin in a child with lymphoblastic lymphoma suggestive of hypersensitivity. Prabu R, Bakhshi S. Pediatr Blood Cancer. 2009 Jan;52(1):148.
  • Autologous hematopoietic stem cell transplantation-what determines the outcome: an experience from North India. Kumar L, Malik PS, Prakash G, Prabu R, Radhakrishnan V, Kayal S, Hariprasad R. Ann Hematol. 2011 Mar 16. [Epub ahead of print]
  • A study of triple-negative breast cancer at a cancer institute in India. J Clin Oncol 29: 2011 (suppl; abstr e11548)
  • PNET spine: morbid and mortal, but ignored till late. Prabu R, Thulkar S, Chand Sharma M, Mohanti BK, Dhawan D, Bakhshi S. J Pediatr Hematol Oncol. 2012 May;34(4):e164-9.
  • Primary cardiac angiosarcoma with good response to Paclitaxel. Ram Prabu MP, Thulkar S, Ray R, Bakhshi S. J Thorac Oncol. 2011 Oct;6(10):1778-9.

Back to Our Doctors